Company Search:
Advanced Search
Sponsored Links
Medlab Clinical Ltd Company Snapshot
Medlab Clinical Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medlab Clinical Ltd with three other companies in this sector in AUSTRALIA : Imugene Limited (2020 sales of 4.21 million Australian Dollars [US$3.25 million] of which 100% was Health technologies), Paradigm Biopharmaceuticals Ltd (4.70 million Australian Dollars [US$3.62 million] ), and Starpharma Holdings Limited (7.12 million Australian Dollars [US$5.49 million] of which 100% was Discovery, development & commercial of D).

Sales Analysis. During the second fiscal quarter of 2021, sales at Medlab Clinical Ltd totalled A$3.97 million. This is an increase of 57.4% from the A$2.52 million in sales at the company during the second quarter of 2020. Medlab Clinical Ltd reported sales of A$5.37 million (US$4.14 million) for the fiscal year ending June of 2020. This represents a sharp decrease of 31.1% versus 2019, when the company's sales were A$7.80 million. Contributing to the drop in overall sales was the 77.4% decline in Corporate/ Other, from A$336,467.00 to A$76,142.00 . There were also decreases in sales in Nutraceutical (down 57.5% to A$2.16 million) . However, these declines were partially offset by the increase in sales of Pharmaceutical Research (up 34.2% to A$3.58 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medlab Clinical Ltd
  Stock Performance Chart for Medlab Clinical Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .17
(Figures in Australian Dollars)
1 Week -2.9%   13 Weeks 0.0%  
4 Weeks -43.3%   52 Weeks -17.1%  
Medlab Clinical Ltd Key Data:
  Ticker: MDC Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 5,369,222
(Year Ending Jan 2021).
Employees: N/A
  Currency: Australian Dollars Market Cap: 47,544,864
  Fiscal Yr Ends: June Shares Outstanding: 279,675,671
  Share Type: Ordinary Closely Held Shares: 147,015,245
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.